Navigation Links
Celldex Therapeutics Receives Fast-Track Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma
Date:1/7/2008

uture experience and results to differ materially from those discussed in these forward-looking statements. Important factors that might cause such a difference include, but are not limited to, costs related to the Merger, failure of AVANT's stockholders to approve the Merger; AVANT's or Celldex's inability to satisfy the conditions of the Merger; AVANT's inability to maintain its NASDAQ listing; the risk that AVANT's and Celldex's businesses will not be integrated successfully; the combined company's inability to further identify, develop and achieve commercial success for new products and technologies; the possibility of delays in the research and development necessary to select drug development candidates and delays in clinical trials; the risk that clinical trials may not result in marketable products; the risk that the combined company may be unable to successfully secure regulatory approval of and market its drug candidates; the risks associated with reliance on outside financing to meet capital requirements; risks associated with Celldex's new and uncertain technology; risks of the development of competing technologies; risks related to the combined company's ability to protect its proprietary technologies; risks related to patent-infringement claims; risks of new, changing and competitive technologies and regulations in the U.S. and internationally; and other events and factors disclosed previously and from time to time in AVANT's filings with the Securities and Exchange Commission, including AVANT's Annual Report on Form 10-K for the year ended December 31, 2006. The companies do not undertake any obligation to release publicly any revisions to such forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

This communication may be deemed to be solicitation material in respect of the proposed merger of AVANT and Celldex. In connection with the proposed merger, AVANT and C
'/>"/>

SOURCE Celldex Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Celldex Therapeutics Announces Orphan Drug Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma Multiforme
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
4. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
5. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
6. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
7. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
8. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
9. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
10. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
11. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... Connected health infrastructure is emerging as ... aiding diagnosis, monitoring and prevention in the healthcare ... stakeholders must first ensure that interoperability and connectivity ... http://photos.prnewswire.com/prnh/20150526/218313LOGO New analysis ... Connectivity and Interoperability, finds that the adoption of ...
(Date:5/26/2015)... 2015  InMed Pharmaceuticals Inc. ("InMed") (CSE: IN; ... a provisional patent application with the United States ... treatment of Epidermolysis Bullosa Simplex (EBS) using novel ... Dr. Sazzad Hossain , ... excited to file our first patent covering the ...
(Date:5/22/2015)... May 22, 2015  Research and Benchmarking firm, ... Medical Affairs Roundtable on Thursday, May ... virtual roundtable to discuss "Medical Affairs, Role in ... Practices, Medical Affairs Consortium provides Medical Affairs leaders ... key challenges they face. The consortium has developed ...
Breaking Medicine Technology:Interoperability among Connected Medical Devices Can Potentially Transform Healthcare 2Interoperability among Connected Medical Devices Can Potentially Transform Healthcare 3InMed Pharmaceuticals Files Provisional Patent Covering Novel Compounds for Treating Epidermolysis Bullosa Simplex (EBS) 2InMed Pharmaceuticals Files Provisional Patent Covering Novel Compounds for Treating Epidermolysis Bullosa Simplex (EBS) 3Best Practices Sixth Medical Affairs Consortium Roundtable to Focus on Health Economics & Outcomes Research 2
(Date:5/26/2015)... Pass, OR (PRWEB) May 26, 2015 ... always fatal if not caught early. Melanoma is also ... water advocate Sharon Kleyne, the melanoma rate is on ... radiation. While the melanoma risk for indoor tanning salon ... these establishments. The most recent ban, in Pennsylvania, coincides ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 Learning ZoneXpress ... line, Nutrition Education Cards . These cards have ... engaging photography and simple, easy-to-read text, these new educational ... . They offer practical nutrition tips and suggestions to ... titles available are: , + MyPlate: Eat for a ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 General ... with MarkLogic Corporation. The alliance ensures joint customers ... platform and General Networks’ expertise in building enterprise ... and MarkLogic will help customers integrate, manage and ... and business processes. , “Our customers are seeking ...
(Date:5/26/2015)... 26, 2015 Javon Bea President ... responsible for using her quality improvement and organizational development ... Denise also provides leadership and direction for the financial, ... Mercy Home Health Care and Mercy Durable Medical Equipment. ... care administration with the last 20 in home care ...
(Date:5/26/2015)... Boston, MA. (PRWEB) May 26, 2015 ... Standing option in their online Master of Social ... Program sites and on the Charles River Campus, the ... , This Advanced Standing option is open ... by the Council on Social Work Education. Students entering ...
Breaking Medicine News(10 mins):Health News:Skin Cancer Awareness Month: Pennsylvania Ban of Teens from Tanning Salons Is Praised by Fresh Water Advocate Sharon Kleyne 2Health News:Skin Cancer Awareness Month: Pennsylvania Ban of Teens from Tanning Salons Is Praised by Fresh Water Advocate Sharon Kleyne 3Health News:Learning ZoneXpress Introduces New Educational Resource for WIC, SNAP-Ed, and EFNEP 2Health News:General Networks Corporation Announces Alliance with MarkLogic 2Health News:Boston University to Offer Online Master of Social Work Advanced Standing Option 2Health News:Boston University to Offer Online Master of Social Work Advanced Standing Option 3
... an interesting manifestation of post traumatic stress disorder (PTSD) - ... frequented chat rooms while at work, his employers, the ... the 58-year old James Pacenza is suing them for $ ... IBM should have offered him sympathy and treatment instead of ...
... report [Thursday, 24 May 2007] the BMA says it is extremely ... in law enforcement situations, in the belief that these can ... produced by the BMAs Board of Science, concludes that it is ... the right individuals in a way that is both effective and ...
... In a move to improve global public health, Weill ... heart disease drug onto the World Health Organization's ... guideline for developing countries to choose which high-priority drugs ... ,Students from Weill Cornell's chapter of Universities Allied for ...
... shown that too much heat can decrease sperm count, and retard ... Bourn Hall Clinic in Cambridgeshire have suggested that soaking up the ... fathering a child. ,Many couples believe that a foreign ... up fully. ,However, sperm takes eight weeks to ...
... Field was diagnosed with osteoporosis in 2005, it was a ... had always exercised, and I had always taken calcium,' Field ... a good girl all the way down the line, but ... in town to talk to legislators at a Capitol Hill ...
... of cancer they say will aid the search for cancer-causing ... ,The study was conducted by a team ... at the Dana-Farber Cancer Institute. ,Conventional mouse models ... embryo. , "You plug it into the mouse, ...
Cached Medicine News:Health News:Sacked Employee Says Stress Led to His Sex Addiction 2Health News:Using Drugs as Weapons can Never Be 'non Lethal', Say Doctors 2Health News:Medical College Students Help Change Global Health Policy 2Health News:Actress Sally Field Vows to Fight Against Osteoporosis 2Health News:Actress Sally Field Vows to Fight Against Osteoporosis 3Health News:New Mouse Model to Aid in Cancer-causing Genes Hunt 2
HYDRACLEAR is our brandname for a remarkable moisture rich element that lies throughout the interior and exterior of the ACUVUE ADVANCE Brand Contact Lenses creating a unique soft, silky feel....
... For use in the percutaneous retrieval of ... or wire guides, and other foreign objects. ... snare around the lead body. It is delivered ... long, flexible 12 Fr cannula that is placed ...
... existing patented technologies such as Simtec ... with the new innovations of automated ... determination, and intelligent collision avoidance in ... treatment delivery with enhanced patient safety. ...
Clinac EX Platinum accelerators offer all the high performance features of the EX series and come standard with the latest high-precision dose sculpting technology for advanced tumor control....
Medicine Products: